Insiders who reported open-market trades in the last 12 months at the companies Kevin Bitterman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
AI DMI LLC - $59.87M in IRON purchases and sales in the last 12 months
John D. Quisel - $8.31M in IRON purchases and sales in the last 12 months
Jonathan Yen-Wen Yu - $5.59M in IRON purchases and sales in the last 12 months
Kevin Bitterman is a corporate insider, tracked as Director of Disc Medicine, Inc. (IRON). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kevin Bitterman submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Kevin Bitterman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 67 open-market sales ($42.93M) across all tracked filings.
Kevin Bitterman is Director of Disc Medicine, Inc. (IRON). 13 SEC Form 4 filings on record going back to 2025, most recently on 15 September 2026. Most recent open-market trade: sold $1.90M of IRON on 15 September 2026. Lifetime open-market sales: $42.93M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Kevin Bitterman.
InsiderAlpha's records for Kevin Bitterman go back to 2025: 13 primary Form 4 filings, an average of 6.5 per year. 15 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
